
Kaiser Permanente Issues Anthrax Clinical Guidelines Update For Physicians And Nurses
This guideline is informational
only and is not intended or designed as a substitute for the reasonable
exercise of independent clinical judgment by providers in any particular
set of circumstances.
Significant change: Nasal
swabs are no longer recommended, per Mid-Atlantic Permanente Medical
Group infectious disease specialists and based on conversations with
the Centers for Disease Control and Prevention (CDC).
Outpatient
triage/treatment guidelines for physicians
Triage guidelines for advice nurses
For more information about
anthrax
Outpatient
triage/treatment guidelines for physicians
Patients from a designated exposure
site
Brentwood mail facility, Air Mail facility
near BWI, Shady Grove bulk mail facility, Merrifield bulk mail facility,
any postal worker or mail room employee who handles federal mail in
Maryland, Virginia, or Washington D.C., contracted employees who pick
up bulk mail from Brentwood, children who visited a parent in the
mail handling area at Brentwood
Note: Customer postal access
areas are not considered at risk
If the patient is symptomatic
and unstable (headache, profuse sweating, achiness, fever, coughing,
chest pain, or difficulty breathing):
- blood cultures and serology for Bacillus
anthracis IgG and IgM
- swab of skin lesion for gram stain and culture
- start IV Cipro 400mg
- send to ER
If the patient is symptomatic
and stable (skin lesion with black center, nasal congestion, rhinorrhea,
and/or sore throat:
- blood cultures
- draw 1 red top tube to hold in lab for possible
future serology
- STAT CBC, electrolytes, BUN, Creatinine
- pulse oximetry
- chest X-ray (attention to mediastinum)
Patient who is afebrile with normal
chest X-ray, normal CBC, and normal pulse oximetry may be sent home
with 10-day supply of Cipro 500-mg po bid. Review pharmacy profile
for potential drug interactions with Cipro prior to prescribing drug.
If the patient is pregnant or pediatric,
consult infectious disease physician on call to discuss drug treatment.
If the patient is asymptomatic:
- Send to the Washington D.C. evaluation site:
D.C. General Hospital, 1900 Massachusetts Ave, SE.
Postal employees can call: 1-866-545-8777.
- By day 7, the public health department will
notify workers who have positive nasal swabs, who will receive
additional Cipro if needed.
- Workers who have not had nasal swabs done
and who are on Cipro will receive additional Cipro by day 7 if
their workplace tests positive for anthrax spores.
- The public health department will not notify
workers who have negative nasal swabs.
Physicians who have questions about
individual patients with symptoms should consult with the infectious
disease physician on call.
For information on clinical features,
diagnoses, and medical management of anthrax, refer to document titled
"Anthrax" that was emailed on October 17, 2001.
Patients not admitted to the hospital
should have appointment with primary care physician the next day.
If you suspect anthrax infection,
you must call the appropriate public health department. You should
also notify the local law enforcement agency.
Back to top of page
Triage
guidelines for advice nurses
Guidelines for advice nurses who
receive calls from patients regarding anthrax
Advice nurse reviews the patients’ symptoms
and the patients’ environment:
- Does the patient have symptoms consistent
with an anthrax exposure?
- Where does patient work? Is it a known exposure?
Is patient a postal worker?
- Has the patient had contact with a suspicious
substance?
Patients from a designated exposure
site
Brentwood mail facility, Air Mail facility
near BWI, Shady Grove bulk mail facility, Merrifield bulk mail facility,
any postal worker or mail room employee who handles federal mail in
Maryland, Virginia, or Washington D.C., contracted employees who pick
up bulk mail from Brentwood, children who visited a parent in the
mail handling area at Brentwood
Note: Customer postal access
areas are not considered at risk
If the patient is symptomatic
and unstable by 911 criteria (headache,
profuse sweating, achiness, fever, coughing, chest pain, and/or difficulty
breathing):
- send patient to nearest ER
- document which ER
- notify ER
If the patient is symptomatic
and stable by 911 criteria (headache, profuse sweating, achiness,
fever, coughing, chest pain, and/or difficulty breathing):
- send patient to ER
- document which ER
- notify ER
If the patient is asymptomatic:
- Send to the Washington D.C. evaluation site:
D.C. General Hospital, 1900 Massachusetts Ave, SE.
Postal employees can call: 1-866-545–8777.
- By day 7, the public health department will
notify workers who have positive nasal swabs, who will receive
additional Cipro if needed.
- Workers who have not had nasal swabs done
and who are on Cipro will receive additional Cipro by day 7 if
their workplace tests positive for anthrax spores.
- The public health department will not notify
workers who have negative nasal swabs.
- Note: Workers at the Shady Grove bulk
mail facility will receive prophylactic antibiotics from the health
department on Thursday, Friday, and Saturday; they will distribute
at the work site.
Postal worker from non-designated
exposure site
If the patient is symptomatic with fever,
headache, sweating, achiness, coughing, chest pain, difficulty breathing:
- send patient to ER
- document which ER
- notify ER
If the patient is symptomatic with
skin lesion with black center, nasal congestion, rhinorrhea, and/or
sore throat:
- send to medical center for clinical evaluation
within 12 hours
If the patient is asymptomatic:
- Chemoprophylaxis is only prescribed based
on a confirmed anthrax exposure and/or threat assessment under
the direction of the public health department and law enforcement
agencies. CDC surveillance protocols are in place to help identify
potential exposure sites.
- If you would like more information about
anthrax, please visit the CDC
Web site.
Patient has had contact with a
suspicious substance (i.e., brown granular substance in mail or
packages)
If the patient is symptomatic with fever,
headache, sweating, achiness, coughing, chest pain, difficulty breathing:
- send patient to ER (advise patient not to
bring substance)
- document which ER
- notify ER
If the patient is symptomatic with
nasal congestion, rhinorrhea, sore throat, and/or skin lesion:
- send to medical center ASAP (within 1-3 hours;
advise patient not to bring substance)
If the patient is asymptomatic:
- Direct the patient to notify local health
and law enforcement officials.
- Chemoprophylaxis is only prescribed based
on a confirmed anthrax exposure and/or threat assessment under
the direction of the public health department and law enforcement
agencies. CDC surveillance protocols are in place to help identify
potential exposure sites.
- Patient is not from a designated exposure
site
Patient is not symptomatic and is not from
a designated exposure site:
- Chemoprophylaxis is only prescribed based
on a confirmed anthrax exposure and/or threat assessment under
the direction of the public health department and law enforcement
agencies.
Back to top of page
If
you would like more information about anthrax
Call local public health department
hotlines:
Washington D.C.:
(202) 442-9196
Fairfax:
(703) 246-3796 (person on phone from 7 a.m. - 11 p.m.)
Montgomery:
(240) 777-4200 (person on phone from 7 a.m. - 10 p.m.)
Or visit the CDC
Web site.
Back to top of page
Updated October 26, 2001
|